Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Steven W Warmann
The BH3 Mimetic ABT-737 Increases Treatment Efficiency of Paclitaxel Against Hepatoblastoma
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
The BH3 Mimetic Drug ABT-737 Induces Apoptosis and Acts Synergistically With Chemotherapeutic Drugs in Thyroid Carcinoma Cells
Cancer Cell International
Cancer Research
Oncology
Genetics
BCL-xL-Inhibitory BH3 Mimetics (ABT-737 or ABT-263) and the Modulation of Cytosolic Calcium Flux and Platelet Function
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Comparison of Putative BH3 Mimetics AT-101, HA14-1, Sabutoclax and TW-37 With ABT-737 in Platelets
Platelets
Medicine
Hematology
Synergistic BCL-2 Inhibition by ABT-737 and Cyclosporine A
Apoptosis : an international journal on programmed cell death
Cell Biology
Pharmacology
Biochemistry
Clinical Biochemistry
Cancer Research
Pharmaceutical Science
Increased Lymphocyte Apoptosis in Mouse Models of Colitis Upon ABT-737 Treatment Is Dependent Upon BIM Expression
Clinical and Experimental Immunology
Allergy
Immunology
ABT-737, a Small Molecule BCL-2/BCL-xL Antagonist, Increases Antimitotic-Mediated Apoptosis in Human Prostate Cancer Cells
PeerJ
Genetics
Molecular Biology
Biochemistry
Biological Sciences
Medicine
Agricultural
Neuroscience
BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines
Cancer Cell
Cancer Research
Oncology
Cell Biology
Synergistic Killing of Human Small Cell Lung Cancer Cells by the BCL-2-Inositol 1,4,5-Trisphosphate Receptor Disruptor BIRD-2 and the BH3-mimetic ABT-263
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Microfluidic Profiling of Apoptosis-Related Genes After Treatment With BH3-mimetic Agents in Astrocyte and Glioblastoma Cell Lines
Oncology Reports
Medicine
Cancer Research
Oncology